Keywords: vectura, fiscal, revenues, increase, chippenham, uk-based, says
Vectura's fiscal 2006 revenues increase 67%
Article | 04 June 2007
Chippenham, UK-based Vectura says that, for the fiscal year ended March 31, 2007, its total revenues rose 67% year-on-year, to L14.1 million ($18.9 million), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
